• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Bruce Cree Discusses Multiple Sclerosis Therapy in a Case Management Setting

Article

In this segment, Dr. Bruce Cree, Assistant Professor of Clinical Neurology, Department of Neurology, University of California San Francisco, discusses how he determines the most appropriate medications for his patients, and working with third-party payers.

Deciding which treatment is selected is based upon tolerability and patent preference. It is important to give patient's different treatment options available in managed care plans. Dr. Cree addresses the potential harm of using third-party preferred medications.

Related Videos
Donna Culton, MD
Margaret Krackeler, MD
Philip Mease, MD
Jerry Shapiro, MD
Paul Nghiem, MD, PhD
Lawrence Eichenfield, MD
Daniel Siegel, MD
James Song, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Related Content
Roberto Mina, MD, Winship Cancer Institute of Emory University

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

January 23rd 2026
Article

The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple myeloma, explained Roberto Mina, MD.

Read More

managed care cast logo

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

January 27th 2026
Podcast

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Mitzi Wasik, PharmD, MBA, BCPS, FAMCP, FCCP, executive director of the AMCP Foundation and senior vice president of Practice Strategy and Innovation at AMCP | Image credit: AMCP

RWD Is Transforming Mental Health, Neurology Managed Care: Mitzi Wasik, PharmD

January 22nd 2026
Article

There is a shift happening in mental health care, with real-world data and holistic evaluations improving patient outcomes and reducing disparities.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Jose Guzman Garcia, PharmD, MHA, BCCCP, associate chief pharmacy officer, UC Davis Health

Pharmacy Innovations That Improve Care Quality, Cut Costs: A Q&A With Jose Guzman Garcia, PharmD, MHA, BCCCP

January 16th 2026
Article

Jose Guzman Garcia, PharmD, MHA, BCCCP, discusses key pharmacy initiatives at UC Davis Health.

Read More

AJMC interview with Dr Roy O. Mathew | Background image credit ipopba - stock.adobe.com

CKM Care Requires Patient Engagement, Lifestyle, and AI: Roy Mathew, MD

January 12th 2026
Article

Roy Mathew, MD, discusses integrating nephrology and cardiology to bridge the gap in patient adherence and care delivery.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.